# MX1

## Overview
The MX1 gene encodes the MX dynamin-like GTPase 1 protein, a member of the large GTPase family, which plays a pivotal role in the innate immune response against viral infections. This protein is primarily induced by type I and type III interferons and is known for its antiviral activity, particularly against influenza viruses. MX dynamin-like GTPase 1 functions by inhibiting viral replication through interactions with viral components, thereby preventing their nuclear import and subsequent replication. Structurally, the protein is characterized by a conserved GTPase domain, a middle domain, and a GTPase effector domain, which facilitate its oligomerization and antiviral function. The MX1 gene's expression and function have significant clinical implications, including associations with autoimmune disorders like alopecia areata and various cancers, where it may serve as a prognostic marker or therapeutic target (Nam2022Elucidating; Haller2019Mx; Aljohani2020Myxovirus).

## Structure
The MX1 protein, also known as MX dynamin-like GTPase 1, is a member of the large GTPase family, which includes dynamins. It is characterized by a conserved N-terminal GTPase domain, a middle domain (MD), and a C-terminal GTPase effector domain (GED) (Verhelst2013Mx). The GTPase domain contains a tripartite GTP-binding motif and a dynamin signature, which are crucial for its GTPase activity (Verhelst2013Mx). 

The tertiary structure of MX1 involves a stalk region that is essential for oligomerization. This region facilitates the formation of ring-like oligomers, with the stalk domains pointing inward and the GTPase domains at the periphery (Verhelst2015Functional). The bundle signaling element (BSE) connects the GTPase domain with the stalk, playing a critical role in transmitting conformational changes necessary for antiviral function (Gao2011Structure).

MX1 proteins oligomerize into tetramers and further into large filaments and rings, which are essential for their antiviral activity (Verhelst2013Mx). The oligomerization is mediated by interactions between the stalk domains and between the BSE and the stalk of neighboring monomers (Verhelst2013Mx). Common post-translational modifications include phosphorylation, which may regulate its activity and function.

## Function
The MX1 gene encodes the MxA protein, a member of the dynamin superfamily of large GTPases, which plays a crucial role in the antiviral defense mechanism in humans. MxA is primarily active in the cytoplasm and is induced by type I and type III interferons (Ciancanelli2016Host; Haller2019Mx). The protein functions by inhibiting the replication of various viruses, including influenza A virus (IAV), by binding to the viral nucleoprotein (NP) and retaining the viral genomic RNA in the cytoplasm near the late endosome (Ciancanelli2016Host). This action prevents the transport of viral components into the nucleus, thereby blocking early steps in the viral life cycle (Haller2019Mx).

MxA's antiviral activity requires GTPase activity and oligomerization, which are essential for its function (Haller2019Mx). The protein can form large self-assemblies in the cytosol, sequestering viral nucleoproteins into membrane-less complexes, although the precise mechanism remains partially understood (Haller2019Mx). MxA's activity may also involve interactions with other cellular factors, such as RNA helicases and chromatin remodeling factors, and it may act as an inflammasome sensor in respiratory epithelial cells, triggering an inflammatory response to control viral infection (Haller2019Mx).

## Clinical Significance
The MX1 gene, encoding the MX dynamin-like GTPase 1 protein, is implicated in several clinical conditions due to its role in antiviral defense and immune response. Alterations in MX1 expression have been associated with alopecia areata (AA), a chronic inflammatory disease characterized by patchy hair loss. A polymorphism in the MX1 gene (+9959) has shown a significant association with AA, particularly in patients with early-onset patchy AA, suggesting a genetic susceptibility locus on chromosome 21 (TaziAhnini2000Structure).

In cancer, MX1 is overexpressed in various types, including breast cancer (BC), where it is linked to aggressive tumor features and poor patient outcomes. High MX1 expression correlates with large tumor size, high grade, hormone receptor negativity, and high Ki67 expression, making it an independent predictor of short BC-specific survival (Aljohani2020Myxovirus).

MX1 also plays a role in resistance to viral infections, such as influenza. In mice, specific mutations in the Mx1 gene can confer resistance to influenza A virus, highlighting its importance in antiviral defense mechanisms (Nam2022Elucidating). These findings underscore the clinical significance of MX1 in both autoimmune disorders and cancer, as well as its potential as a therapeutic target.

## Interactions
The MX1 protein, also known as MX dynamin-like GTPase 1, is involved in various protein interactions that contribute to its antiviral activity. MX1 interacts with components of the viral ribonucleoprotein (vRNP) complex, specifically targeting the nucleoprotein (NP) and polymerase basic protein 2 (PB2) of the influenza virus. This interaction disrupts the assembly of the vRNP complex, thereby inhibiting viral replication (Verhelst2012Interferon-Inducible). 

MX1 also associates with nuclear structures, forming nuclear dots that are often linked to promyelocytic leukemia protein nuclear bodies (PML NBs). It interacts with proteins such as Sp100, Daxx, and components of the SUMO-1 protein modification system, although these interactions are not essential for its antiviral function (Engelhardt2001InterferonInduced; Haller2007Interferon-induced). 

In addition, MX1's interaction with the SUMOylation machinery, including SUMO1 and Ubc9, is noted, although covalent modification by SUMO is not critical for its antiviral activity (BrantisdeCarvalho2015MxA). These interactions highlight MX1's role in the cellular antiviral response, particularly against influenza viruses.


## References


[1. (Haller2007Interferon-induced) Otto Haller, Peter Staeheli, and Georg Kochs. Interferon-induced mx proteins in antiviral host defense. Biochimie, 89(6–7):812–818, June 2007. URL: http://dx.doi.org/10.1016/j.biochi.2007.04.015, doi:10.1016/j.biochi.2007.04.015. This article has 481 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.biochi.2007.04.015)

[2. (Ciancanelli2016Host) Michael J Ciancanelli, Laurent Abel, Shen-Ying Zhang, and Jean-Laurent Casanova. Host genetics of severe influenza: from mouse mx1 to human irf7. Current Opinion in Immunology, 38:109–120, February 2016. URL: http://dx.doi.org/10.1016/j.coi.2015.12.002, doi:10.1016/j.coi.2015.12.002. This article has 119 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.coi.2015.12.002)

[3. (Verhelst2012Interferon-Inducible) Judith Verhelst, Eef Parthoens, Bert Schepens, Walter Fiers, and Xavier Saelens. Interferon-inducible protein mx1 inhibits influenza virus by interfering with functional viral ribonucleoprotein complex assembly. Journal of Virology, 86(24):13445–13455, December 2012. URL: http://dx.doi.org/10.1128/JVI.01682-12, doi:10.1128/jvi.01682-12. This article has 262 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/JVI.01682-12)

[4. (Nam2022Elucidating) Hajin Nam, Boyoung Kim, Avishekh Gautam, Yoo Yeon Kim, Eun Sun Park, Jong Sun Lee, Hyung-Joo Kwon, Je Kyung Seong, and Jun Gyo Suh. Elucidating the characteristics of mx1 and resistance to influenza a virus subtype h1n1 in the newly developed kwm/hym mice. Laboratory Animal Research, September 2022. URL: http://dx.doi.org/10.1186/s42826-022-00138-z, doi:10.1186/s42826-022-00138-z. This article has 2 citations.](https://doi.org/10.1186/s42826-022-00138-z)

[5. (TaziAhnini2000Structure) Rachid Tazi-Ahnini, Francesco S. di Giovine, Andrew J.G. McDonagh, Andrew G. Messenger, Claire Amadou, Angela Cox, Gordon W. Duff, and Michael J. Cork. Structure and polymorphism of the human gene for the interferon-induced p78 protein (mx1): evidence of association with alopecia areata in the down syndrome region. Human Genetics, 106(6):639–645, May 2000. URL: http://dx.doi.org/10.1007/s004390000318, doi:10.1007/s004390000318. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s004390000318)

[6. (Haller2019Mx) Otto Haller and Georg Kochs. Mx genes: host determinants controlling influenza virus infection and trans-species transmission. Human Genetics, 139(6–7):695–705, November 2019. URL: http://dx.doi.org/10.1007/s00439-019-02092-8, doi:10.1007/s00439-019-02092-8. This article has 43 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00439-019-02092-8)

[7. (BrantisdeCarvalho2015MxA) Carlos Eduardo Brantis-de-Carvalho, Ghizlane Maarifi, Paulo Eduardo Gonçalves Boldrin, Cleslei Fernando Zanelli, Sébastien Nisole, Mounira K. Chelbi-Alix, and Sandro Roberto Valentini. Mxa interacts with and is modified by the sumoylation machinery. Experimental Cell Research, 330(1):151–163, January 2015. URL: http://dx.doi.org/10.1016/j.yexcr.2014.10.020, doi:10.1016/j.yexcr.2014.10.020. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.yexcr.2014.10.020)

[8. (Aljohani2020Myxovirus) Abrar I. Aljohani, Chitra Joseph, Sasagu Kurozumi, Omar J. Mohammed, Islam M. Miligy, Andrew R. Green, and Emad A. Rakha. Myxovirus resistance 1 (mx1) is an independent predictor of poor outcome in invasive breast cancer. Breast Cancer Research and Treatment, 181(3):541–551, April 2020. URL: http://dx.doi.org/10.1007/S10549-020-05646-X, doi:10.1007/s10549-020-05646-x. This article has 34 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/S10549-020-05646-X)

[9. (Engelhardt2001InterferonInduced) Othmar G. Engelhardt, Evelyn Ullrich, Georg Kochs, and Otto Haller. Interferon-induced antiviral mx1 gtpase is associated with components of the sumo-1 system and promyelocytic leukemia protein nuclear bodies. Experimental Cell Research, 271(2):286–295, December 2001. URL: http://dx.doi.org/10.1006/excr.2001.5380, doi:10.1006/excr.2001.5380. This article has 58 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/excr.2001.5380)

[10. (Gao2011Structure) Song Gao, Alexander von der Malsburg, Alexej Dick, Katja Faelber, Gunnar F. Schröder, Otto Haller, Georg Kochs, and Oliver Daumke. Structure of myxovirus resistance protein a reveals intra- and intermolecular domain interactions required for the antiviral function. Immunity, 35(4):514–525, October 2011. URL: http://dx.doi.org/10.1016/j.immuni.2011.07.012, doi:10.1016/j.immuni.2011.07.012. This article has 186 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.immuni.2011.07.012)

[11. (Verhelst2013Mx) Judith Verhelst, Paco Hulpiau, and Xavier Saelens. Mx proteins: antiviral gatekeepers that restrain the uninvited. Microbiology and Molecular Biology Reviews, 77(4):551–566, December 2013. URL: http://dx.doi.org/10.1128/mmbr.00024-13, doi:10.1128/mmbr.00024-13. This article has 237 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mmbr.00024-13)

[12. (Verhelst2015Functional) Judith Verhelst, Jan Spitaels, Cindy Nürnberger, Dorien De Vlieger, Tine Ysenbaert, Peter Staeheli, Walter Fiers, and Xavier Saelens. Functional comparison of mx1 from two different mouse species reveals the involvement of loop l4 in the antiviral activity against influenza a viruses. Journal of Virology, 89(21):10879–10890, November 2015. URL: http://dx.doi.org/10.1128/jvi.01744-15, doi:10.1128/jvi.01744-15. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/jvi.01744-15)